{ "name": "Apogee Therapeutics, Inc.", "slug": "apogee-therapeutics-inc", "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.", "status": "complete", "updated_at": "2026-08-06T08:08:36Z", "nasdaq_status": "retrieved", "latest_market": "2026-08-05: stängning 134.23, volym 1961062", "mfn_status": "skipped", "mfn_count": 0, "nasdaq_reports_status": "skipped", "reports": { "available": false, "url": "/company/apogee-therapeutics-inc/reports", "count": 0, "nasdaq_count": 0, "mfn_fallback_count": 0, "items": [] }, "report_count": 0, "nasdaq_report_count": 0, "mfn_fallback_count": 0, "sec_status": "retrieved", "sec_count": 67, "fi_status": "skipped", "fi_summary": {}, "warnings": [], "source_identity": { "nasdaq_reports": null, "mfn": null, "sec": { "status": "resolved", "method": "explicit_ticker", "expected_name": "Apogee Therapeutics, Inc.", "ticker": "APGE", "title": "Apogee Therapeutics, Inc.", "cik": "0001974640", "match_score": 100.0 }, "nasdaq": null, "finansinspektionen": null }, "documents": [ { "doc_id": "sec-edgar-8-k-2026-06-22-ef20076542-8k-htm", "title": "8-K – 2026-06-22 – ef20076542_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000114036126025841/ef20076542_8k.htm", "date": "2026-06-22", "period": "2026-06-17", "form_type": "8-K", "report_key": null, "filename": "ef20076542_8k.htm", "text_chars": 8462, "sha256": "50f95b8b27f6ec79f1f644a34cebae282ce97836861cdfbc236c20a41e6364e1", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076542-8k-htm/part-001.html", "chars": 8462 } ] }, { "doc_id": "sec-edgar-8-k-2026-06-22-ef20076505-8k-htm", "title": "8-K – 2026-06-22 – ef20076505_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000114036126025844/ef20076505_8k.htm", "date": "2026-06-22", "period": "2026-06-18", "form_type": "8-K", "report_key": null, "filename": "ef20076505_8k.htm", "text_chars": 26507, "sha256": "9a812a5ed68ce73aa5044ed4df768ee3cc23a64cc0506c23f8c36cc614d4e306", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-22-ef20076505-8k-htm/part-001.html", "chars": 26507 } ] }, { "doc_id": "sec-edgar-8-k-2026-06-12-apge-20260609-htm", "title": "8-K – 2026-06-12 – apge-20260609.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm", "date": "2026-06-12", "period": "2026-06-09", "form_type": "8-K", "report_key": null, "filename": "apge-20260609.htm", "text_chars": 4316, "sha256": "6febecb740b8c2ca122d2f0c8b67a1875acf1cdc52f211c4bace1998e9b812df", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-06-12-apge-20260609-htm/part-001.html", "chars": 4316 } ] }, { "doc_id": "sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm", "title": "8-K – 2026-05-27 – tm2615568d2_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926066575/tm2615568d2_8k.htm", "date": "2026-05-27", "period": "2026-05-26", "form_type": "8-K", "report_key": null, "filename": "tm2615568d2_8k.htm", "text_chars": 9909, "sha256": "3e119058884c861b41bcd70cc40ffd9dd3d3910526959b6fe08b9d132a60fbc3", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d2-8k-htm/part-001.html", "chars": 9909 } ] }, { "doc_id": "sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm", "title": "8-K – 2026-05-27 – tm2615568d1_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926066572/tm2615568d1_8k.htm", "date": "2026-05-27", "period": "2026-05-27", "form_type": "8-K", "report_key": null, "filename": "tm2615568d1_8k.htm", "text_chars": 14240, "sha256": "e9f52f02aee95959b954f9974664867b0dc6773ba24255e2a3b1c832633dbdcf", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-27-tm2615568d1-8k-htm/part-001.html", "chars": 14240 } ] }, { "doc_id": "sec-edgar-8-k-2026-05-11-apge-20260511-htm", "title": "8-K – 2026-05-11 – apge-20260511.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526215683/apge-20260511.htm", "date": "2026-05-11", "period": "2026-05-11", "form_type": "8-K", "report_key": null, "filename": "apge-20260511.htm", "text_chars": 3710, "sha256": "366e91ea155b40f194dbd649d5a8670764fbc59756d055adcb13d59aabdb80db", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-05-11-apge-20260511-htm/part-001.html", "chars": 3710 } ] }, { "doc_id": "sec-edgar-10-q-2026-05-11-apge-20260331-htm", "title": "10-Q – 2026-05-11 – apge-20260331.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526215698/apge-20260331.htm", "date": "2026-05-11", "period": "2026-03-31", "form_type": "10-Q", "report_key": null, "filename": "apge-20260331.htm", "text_chars": 365772, "sha256": "1b6c38a1697a6533b05bf0e85dadd105712a268fdc06775cf4ef84cf10412e4a", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-001.html", "chars": 177170 }, { "number": 2, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-002.html", "chars": 178121 }, { "number": 3, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2026-05-11-apge-20260331-htm/part-003.html", "chars": 10474 } ] }, { "doc_id": "sec-edgar-8-k-2026-04-24-apge-20260421-htm", "title": "8-K – 2026-04-24 – apge-20260421.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/apge-20260421.htm", "date": "2026-04-24", "period": "2026-04-21", "form_type": "8-K", "report_key": null, "filename": "apge-20260421.htm", "text_chars": 3165, "sha256": "0ca7d58b2068e0ccbe254b53a630fcc31aa400702baae934bef28e443ed59fd7", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-04-24-apge-20260421-htm/part-001.html", "chars": 3165 } ] }, { "doc_id": "sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm", "title": "8-K – 2026-03-25 – tm269761d1_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/tm269761d1_8k.htm", "date": "2026-03-25", "period": "2026-03-24", "form_type": "8-K", "report_key": null, "filename": "tm269761d1_8k.htm", "text_chars": 5313, "sha256": "fe3c1aabb7eb1e8db7940b85e32c0a7ae1f8fbc20780a6ca5fe3ba08a07f7922", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-25-tm269761d1-8k-htm/part-001.html", "chars": 5313 } ] }, { "doc_id": "sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm", "title": "8-K – 2026-03-23 – tm269553d1_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926032950/tm269553d1_8k.htm", "date": "2026-03-23", "period": "2026-03-23", "form_type": "8-K", "report_key": null, "filename": "tm269553d1_8k.htm", "text_chars": 8120, "sha256": "91d33eb59987087e8590bf15e15cf129f6be1e931a4aad99e4f57461acb7e561", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-23-tm269553d1-8k-htm/part-001.html", "chars": 8120 } ] }, { "doc_id": "sec-edgar-8-k-2026-03-02-apge-20260302-htm", "title": "8-K – 2026-03-02 – apge-20260302.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000197464026000001/apge-20260302.htm", "date": "2026-03-02", "period": "2026-03-02", "form_type": "8-K", "report_key": null, "filename": "apge-20260302.htm", "text_chars": 3715, "sha256": "0c96e83aa3e34509a17bb0cbd9e092d1e0a2c847d7fe561c26edd9359a3dd2f2", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-03-02-apge-20260302-htm/part-001.html", "chars": 3715 } ] }, { "doc_id": "sec-edgar-10-k-2026-03-02-apge-20251231-htm", "title": "10-K – 2026-03-02 – apge-20251231.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000197464026000002/apge-20251231.htm", "date": "2026-03-02", "period": "2025-12-31", "form_type": "10-K", "report_key": null, "filename": "apge-20251231.htm", "text_chars": 627504, "sha256": "2b3f75f212149491252b7777c9b2fbcf457be175588982d62df061f3abeaef96", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-001.html", "chars": 178948 }, { "number": 2, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-002.html", "chars": 179198 }, { "number": 3, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-003.html", "chars": 178445 }, { "number": 4, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-k-2026-03-02-apge-20251231-htm/part-004.html", "chars": 90901 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm", "title": "8-K – 2026-01-06 – tm261950d1_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465926001063/tm261950d1_8k.htm", "date": "2026-01-06", "period": "2026-01-06", "form_type": "8-K", "report_key": null, "filename": "tm261950d1_8k.htm", "text_chars": 11740, "sha256": "9cdce08caac5ae19d21f606f31a9b7b68c8ffb29bde6296df26f09e5c8373270", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2026-01-06-tm261950d1-8k-htm/part-001.html", "chars": 11740 } ] }, { "doc_id": "sec-edgar-8-k-2025-11-10-apge-20251110-htm", "title": "8-K – 2025-11-10 – apge-20251110.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312525273250/apge-20251110.htm", "date": "2025-11-10", "period": "2025-11-10", "form_type": "8-K", "report_key": null, "filename": "apge-20251110.htm", "text_chars": 4463, "sha256": "fbbca606e8d8e3407a83efd78febbce3e345a52f244900f91b8aa6e80f3335be", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-11-10-apge-20251110-htm/part-001.html", "chars": 4463 } ] }, { "doc_id": "sec-edgar-10-q-2025-11-10-apge-20250930-htm", "title": "10-Q – 2025-11-10 – apge-20250930.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000119312525273260/apge-20250930.htm", "date": "2025-11-10", "period": "2025-09-30", "form_type": "10-Q", "report_key": null, "filename": "apge-20250930.htm", "text_chars": 408947, "sha256": "50a855d5c18b1b2e0d7fac27c6932f4b04655836af4fe74291b2ce45fa85d984", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-001.html", "chars": 178503 }, { "number": 2, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-002.html", "chars": 179640 }, { "number": 3, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-11-10-apge-20250930-htm/part-003.html", "chars": 50797 } ] }, { "doc_id": "sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm", "title": "8-K – 2025-10-10 – tm2528385d1_8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000110465925098487/tm2528385d1_8k.htm", "date": "2025-10-10", "period": "2025-10-08", "form_type": "8-K", "report_key": null, "filename": "tm2528385d1_8k.htm", "text_chars": 6996, "sha256": "dbd3dcbeab6bd106e3a89f8c9875f449a0e3e2e3010d903cfd7717fa08fe0d14", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-10-10-tm2528385d1-8k-htm/part-001.html", "chars": 6996 } ] }, { "doc_id": "sec-edgar-8-k-2025-08-11-apge-20250811-htm", "title": "8-K – 2025-08-11 – apge-20250811.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000095017025106228/apge-20250811.htm", "date": "2025-08-11", "period": "2025-08-11", "form_type": "8-K", "report_key": null, "filename": "apge-20250811.htm", "text_chars": 3678, "sha256": "31feb86d01a9a76de375b15313a181864575b378f4689fd44d23d03982f206f7", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-8-k-2025-08-11-apge-20250811-htm/part-001.html", "chars": 3678 } ] }, { "doc_id": "sec-edgar-10-q-2025-08-11-apge-20250630-htm", "title": "10-Q – 2025-08-11 – apge-20250630.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/1974640/000095017025106234/apge-20250630.htm", "date": "2025-08-11", "period": "2025-06-30", "form_type": "10-Q", "report_key": null, "filename": "apge-20250630.htm", "text_chars": 394753, "sha256": "e937ce6306c8f5fb880717d11664e32a13d8879a842364adf7d44d9ac4f3cf82", "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm", "txt_url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-001.html", "chars": 179027 }, { "number": 2, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-002.html", "chars": 178910 }, { "number": 3, "url": "/company/apogee-therapeutics-inc/documents/sec-edgar-10-q-2025-08-11-apge-20250630-htm/part-003.html", "chars": 36806 } ] } ], "market_files": [ { "label": "Nasdaq kurshistorik CSV", "url": "/company/apogee-therapeutics-inc/market/history.csv", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/history.csv" }, { "label": "Nasdaq kurshistorik JSON", "url": "/company/apogee-therapeutics-inc/market/history.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/history.json" }, { "label": "Nasdaq manifest JSON", "url": "/company/apogee-therapeutics-inc/market/manifest.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/manifest.json" }, { "label": "SEC Company Facts JSON", "url": "/company/apogee-therapeutics-inc/market/sec-companyfacts.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-companyfacts.json" }, { "label": "SEC filing-manifest JSON", "url": "/company/apogee-therapeutics-inc/market/sec-manifest.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-manifest.json" }, { "label": "SEC sammanfattning JSON", "url": "/company/apogee-therapeutics-inc/market/sec-summary.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc/market/sec-summary.json" } ], "sec_facts": { "status": "summarized", "entity_name": "Apogee Therapeutics, Inc.", "cik": "0001974640", "metrics": [ { "label": "Rörelseresultat", "taxonomy": "us-gaap", "concept": "OperatingIncomeLoss", "description": "The net result for the period of deducting operating expenses from operating revenues.", "label_original": "Operating Income (Loss)", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-11", "value": -82772000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": -63096000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": -285595000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": -216870000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": -93003000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": -207539000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": -140989000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": -136261000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-11", "value": -82303000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-12", "value": -63096000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -38181000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-03-03", "value": -216870000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-03-03", "value": -93003000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-11-12", "value": -140989000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-11-12", "value": -55848000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2024-08-12", "value": -82303000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Nettoresultat", "taxonomy": "us-gaap", "concept": "NetIncomeLoss", "description": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label_original": "Net Income (Loss) Attributable to Parent", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-11", "value": -74111000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": -55339000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-04-24", "value": -255843000, "unit": "USD", "accession": "0001193125-26-177342", "frame": "CY2025" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-04-24", "value": -182146000, "unit": "USD", "accession": "0001193125-26-177342", "frame": "CY2024" }, { "fy": null, "fp": null, "form": "DEF 14A", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-04-24", "value": -83985000, "unit": "USD", "accession": "0001193125-26-177342", "frame": "CY2023" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": -255843000, "unit": "USD", "accession": "0001974640-26-000002", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": -182146000, "unit": "USD", "accession": "0001974640-26-000002", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": -83985000, "unit": "USD", "accession": "0001974640-26-000002", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": -186456000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-04-01", "end": "2025-06-30", "filed": "2025-11-10", "value": -66096000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2025Q2" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-11-10", "value": -55339000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": -114928000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-04-01", "end": "2024-06-30", "filed": "2025-11-10", "value": -33816000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2024Q2" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-11-10", "value": -32094000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2024Q1" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": -121435000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-08-11", "value": -55339000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null } ] }, { "label": "Resultat per aktie, utspätt", "taxonomy": "us-gaap", "concept": "EarningsPerShareDiluted", "description": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label_original": "Earnings Per Share, Diluted", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-11", "value": -1.06, "unit": "USD/shares", "accession": "0001193125-26-215698", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": -0.95, "unit": "USD/shares", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": -4.22, "unit": "USD/shares", "accession": "0001974640-26-000002", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": -3.3, "unit": "USD/shares", "accession": "0001974640-26-000002", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": -3.36, "unit": "USD/shares", "accession": "0001974640-26-000002", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": -3.19, "unit": "USD/shares", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": -2.11, "unit": "USD/shares", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": -2.08, "unit": "USD/shares", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-11", "value": -1.24, "unit": "USD/shares", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-12", "value": -0.95, "unit": "USD/shares", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -0.64, "unit": "USD/shares", "accession": "0000950170-25-068513", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-03-03", "value": -3.3, "unit": "USD/shares", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-03-03", "value": -3.36, "unit": "USD/shares", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-11-12", "value": -2.11, "unit": "USD/shares", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-11-12", "value": -3.04, "unit": "USD/shares", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2024-08-12", "value": -1.24, "unit": "USD/shares", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Kassa", "taxonomy": "us-gaap", "concept": "CashAndCashEquivalentsAtCarryingValue", "description": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label_original": "Cash and Cash Equivalents, at Carrying Value", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-11", "value": 451797000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2026-05-11", "value": 106916000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-03-02", "value": 131549000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-03-02", "value": 141789000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2026-03-02", "value": 118316000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2023Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-11-10", "value": 107914000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-11-10", "value": 118780000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2024Q3I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-11", "value": 124192000, "unit": "USD", "accession": "0000950170-25-106234", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2025-08-11", "value": 307299000, "unit": "USD", "accession": "0000950170-25-106234", "frame": "CY2024Q2I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-12", "value": 106916000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-03-31", "filed": "2025-05-12", "value": 485457000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2024Q1I" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-03-03", "value": 141789000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-03-03", "value": 118316000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-11-12", "value": 118780000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-09-30", "filed": "2024-11-12", "value": 188269000, "unit": "USD", "accession": "0000950170-24-124559", "frame": "CY2023Q3I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-12", "value": 307299000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Tillgångar", "taxonomy": "us-gaap", "concept": "Assets", "description": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label_original": "Assets", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-11", "value": 1293654000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-11", "value": 937134000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-03-02", "value": 937134000, "unit": "USD", "accession": "0001974640-26-000002", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-03-02", "value": 753951000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-11-10", "value": 626159000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-11-10", "value": 753951000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-11", "value": 657772000, "unit": "USD", "accession": "0000950170-25-106234", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-08-11", "value": 753951000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-12", "value": 714162000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-05-12", "value": 753951000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-03-03", "value": 753951000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-03-03", "value": 401404000, "unit": "USD", "accession": "0000950170-25-030385", "frame": "CY2023Q4I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-11-12", "value": 776286000, "unit": "USD", "accession": "0000950170-24-124559", "frame": "CY2024Q3I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-11-12", "value": 401404000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-12", "value": 800657000, "unit": "USD", "accession": "0000950170-24-095053", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-08-12", "value": 401404000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Skulder", "taxonomy": "us-gaap", "concept": "Liabilities", "description": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label_original": "Liabilities", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-11", "value": 37861000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-05-11", "value": 33251000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q4I" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-12-31", "filed": "2026-03-02", "value": 33251000, "unit": "USD", "accession": "0001974640-26-000002", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2026-03-02", "value": 37157000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2025-11-10", "value": 39821000, "unit": "USD", "accession": "0001193125-25-273260", "frame": "CY2025Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-11-10", "value": 37157000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-11", "value": 38371000, "unit": "USD", "accession": "0000950170-25-106234", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-08-11", "value": 37157000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-12", "value": 40800000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-05-12", "value": 37157000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-12-31", "filed": "2025-03-03", "value": 37157000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-12-31", "filed": "2025-03-03", "value": 21491000, "unit": "USD", "accession": "0000950170-25-030385", "frame": "CY2023Q4I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2024-11-12", "value": 41884000, "unit": "USD", "accession": "0000950170-24-124559", "frame": "CY2024Q3I" }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-11-12", "value": 21491000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-12", "value": 27018000, "unit": "USD", "accession": "0000950170-24-095053", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-08-12", "value": 21491000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Operativt kassaflöde", "taxonomy": "us-gaap", "concept": "NetCashProvidedByUsedInOperatingActivities", "description": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label_original": "Net Cash Provided by (Used in) Operating Activities", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-11", "value": -55570000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": -48477000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": -227450000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": -171174000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": -74761000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": -164761000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": -103460000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": -110506000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-11", "value": -60936000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-12", "value": -48477000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -31636000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-03-03", "value": -171174000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-03-03", "value": -74761000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-11-12", "value": -103460000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-11-12", "value": -45007000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2024-08-12", "value": -60936000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null } ] }, { "label": "Investeringar", "taxonomy": "us-gaap", "concept": "PaymentsToAcquirePropertyPlantAndEquipment", "description": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label_original": "Payments to Acquire Property, Plant, and Equipment", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": 4317000, "unit": "USD", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": 5147000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": 1152000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": 167000, "unit": "USD", "accession": "0001974640-26-000002", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": 5085000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": 1153000, "unit": "USD", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": 5085000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-11", "value": 402000, "unit": "USD", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 4317000, "unit": "USD", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-12", "value": 351000, "unit": "USD", "accession": "0000950170-25-068513", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-03-03", "value": 1152000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-03-03", "value": 167000, "unit": "USD", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-11-12", "value": 1153000, "unit": "USD", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2024-08-12", "value": 402000, "unit": "USD", "accession": "0000950170-24-095053", "frame": null }, { "fy": 2024, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2024-05-13", "value": 351000, "unit": "USD", "accession": "0001558370-24-007861", "frame": null }, { "fy": 2023, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2024-03-05", "value": 167000, "unit": "USD", "accession": "0001558370-24-002406", "frame": null } ] }, { "label": "Antal aktier, utspätt", "taxonomy": "us-gaap", "concept": "WeightedAverageNumberOfDilutedSharesOutstanding", "description": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label_original": "Weighted Average Number of Shares Outstanding, Diluted", "facts": [ { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2026-01-01", "end": "2026-03-31", "filed": "2026-05-11", "value": 69668439, "unit": "shares", "accession": "0001193125-26-215698", "frame": "CY2026Q1" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2026-05-11", "value": 58195272, "unit": "shares", "accession": "0001193125-26-215698", "frame": "CY2025Q1" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2025-01-01", "end": "2025-12-31", "filed": "2026-03-02", "value": 60690820, "unit": "shares", "accession": "0001974640-26-000002", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2026-03-02", "value": 55193971, "unit": "shares", "accession": "0001974640-26-000002", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2026-03-02", "value": 25005774, "unit": "shares", "accession": "0001974640-26-000002", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2025-01-01", "end": "2025-09-30", "filed": "2025-11-10", "value": 58467901, "unit": "shares", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2025-11-10", "value": 54508496, "unit": "shares", "accession": "0001193125-25-273260", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2025-01-01", "end": "2025-06-30", "filed": "2025-08-11", "value": 58312452, "unit": "shares", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2025-08-11", "value": 53352406, "unit": "shares", "accession": "0000950170-25-106234", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2025-01-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 58195272, "unit": "shares", "accession": "0000950170-25-068513", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-01-01", "end": "2024-03-31", "filed": "2025-05-12", "value": 50189808, "unit": "shares", "accession": "0000950170-25-068513", "frame": "CY2024Q1" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2024-01-01", "end": "2024-12-31", "filed": "2025-03-03", "value": 55193971, "unit": "shares", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-01-01", "end": "2023-12-31", "filed": "2025-03-03", "value": 25005774, "unit": "shares", "accession": "0000950170-25-030385", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2024-01-01", "end": "2024-09-30", "filed": "2024-11-12", "value": 54508496, "unit": "shares", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": "2023-01-01", "end": "2023-09-30", "filed": "2024-11-12", "value": 17209842, "unit": "shares", "accession": "0000950170-24-124559", "frame": null }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": "2024-01-01", "end": "2024-06-30", "filed": "2024-08-12", "value": 53352406, "unit": "shares", "accession": "0000950170-24-095053", "frame": null } ] } ] }, "morningstar": { "configured": false, "status": "inte hämtad", "captured_at": null, "view_count": 0, "url": "/company/apogee-therapeutics-inc/morningstar" }, "finansinspektionen": { "available": false, "status": "skipped", "url": "/company/apogee-therapeutics-inc/finansinspektionen", "transaction_count": 0, "aggregate_short_percent": null, "files": [] }, "llms_url": "/company/apogee-therapeutics-inc/llms.txt", "json_url": "/company/apogee-therapeutics-inc/company.json", "document_index_url": "/company/apogee-therapeutics-inc/documents.json", "absolute_url": "https://spela.port0.org/company/apogee-therapeutics-inc" }